67 employees
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
2020
$60M
from 4 investors over 4 rounds
Adela, Inc. raised $60M on June 23, 2021
Investors: Decheng Capital, OrbiMed Advisors, F-Prime Capital Partners and RA Capital Management, L.P.